These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 8525463)
1. Ligand selectivity of cloned human and rat opioid mu receptors. Rothman RB; Xu H; Wang JB; Partilla JS; Kayakiri H; Rice KC; Uhl GR Synapse; 1995 Sep; 21(1):60-4. PubMed ID: 8525463 [TBL] [Abstract][Full Text] [Related]
2. 6 beta-[125iodo]-3, 14-dihydroxy-17-methyl-4, 5 alpha-epoxymorphinan ([125I]IOXY-AGO): a potent and selective radioligand for opioid mu receptors. Xu H; Goodman CB; Partilla JS; Ni Q; Kayakiri H; Rice KC; Rothman RB Synapse; 1995 Feb; 19(2):105-11. PubMed ID: 7725239 [TBL] [Abstract][Full Text] [Related]
3. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization. Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901 [TBL] [Abstract][Full Text] [Related]
4. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor. Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512 [TBL] [Abstract][Full Text] [Related]
5. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor. Xu H; Wang X; Wang J; Rothman RB Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220 [TBL] [Abstract][Full Text] [Related]
6. Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents. Deng HB; Guang W; Wang JB J Pharmacol Exp Ther; 2000 Apr; 293(1):113-20. PubMed ID: 10734160 [TBL] [Abstract][Full Text] [Related]
7. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors. Zhao GM; Qian X; Schiller PW; Szeto HH J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366 [TBL] [Abstract][Full Text] [Related]
8. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain. Chaipatikul V; Loh HH; Law PY J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655 [TBL] [Abstract][Full Text] [Related]
9. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor. Xu H; Lu YF; Rothman RB Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the cloned human mu opioid receptor. Raynor K; Kong H; Mestek A; Bye LS; Tian M; Liu J; Yu L; Reisine T J Pharmacol Exp Ther; 1995 Jan; 272(1):423-8. PubMed ID: 7815359 [TBL] [Abstract][Full Text] [Related]
12. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein. Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353 [TBL] [Abstract][Full Text] [Related]
14. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor. Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373 [TBL] [Abstract][Full Text] [Related]
15. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related]
16. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus. Selley DE; Liu Q; Childers SR J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589 [TBL] [Abstract][Full Text] [Related]
17. [Binding characteristics of new synthesized opioid receptor ligands to cloned mu opioid receptors stably expressed in CHO cell]. Hu P; Ye CY; Qiu ZB; Yang HF; Zhang DC Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):79-82. PubMed ID: 12905615 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide. Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687 [TBL] [Abstract][Full Text] [Related]
19. Binding properties of C-truncated delta opioid receptors. Wang CH; Zhou DH; Chen J; Li GE; Pei G; Chi ZQ Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):337-40. PubMed ID: 10072917 [TBL] [Abstract][Full Text] [Related]
20. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum. Capasso A; Sorrentino L Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]